Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Celanese | CE | Mar 14, 2025 | 57.05 | +7.46 |
Celcuity | CELC | Mar 14, 2025 | 10.03 | 0.00 |
Celestica | CLS | Mar 14, 2025 | 91.58 | +5.98 |
Celldex Therapeutics | CLDX | Mar 14, 2025 | 20.42 | +1.39 |
Cellebrite | CLBT | Mar 14, 2025 | 18.25 | +5.61 |
Cellectar Biosciences | CLRB | Mar 14, 2025 | 0.32 | +5.34 |
Cellectis ADR | CLLS | Mar 14, 2025 | 1.24 | -3.88 |
Celsius | CELH | Mar 14, 2025 | 27.08 | +1.69 |
Celularity A | CELU | Mar 14, 2025 | 1.55 | +0.65 |
Cementos Pacasmayo ADR | CPAC | Mar 14, 2025 | 5.70 | -0.96 |
CEMEX ADR | CX | Mar 14, 2025 | 6.02 | +2.56 |
Cemtrex | CETX | Mar 14, 2025 | 1.69 | 0.00 |
Cencora | COR | Mar 14, 2025 | 258.07 | +0.80 |
Cenntro | CENN | Mar 14, 2025 | 0.99 | +1.35 |
Cenovus Energy | CVE | Mar 14, 2025 | 13.49 | +3.21 |
Centene | CNC | Mar 14, 2025 | 58.19 | +0.40 |
CenterPoint Energy | CNP | Mar 14, 2025 | 35.48 | +2.51 |
Centerra Gold | CGAU | Mar 14, 2025 | 5.84 | +0.52 |
Centessa Pharmaceuticals ADR | CNTA | Mar 14, 2025 | 17.14 | +1.60 |
Centrais Electricas Brasileiras B ADR | EBR-B | Mar 14, 2025 | 7.65 | +1.06 |
Centrais Eletricas Brasileiras ADR | EBR | Mar 14, 2025 | 7.03 | +2.63 |
Central Garden & Pet | CENT | Mar 14, 2025 | 36.61 | +1.69 |
Central Garden & Pet A | CENTA | Mar 14, 2025 | 32.34 | +1.28 |
Central Pacific Financial | CPF | Mar 14, 2025 | 27.11 | +2.73 |
Central Plains Bancshares | CPBI | Mar 14, 2025 | 14.76 | +0.07 |
Central Puerto ADR | CEPU | Mar 14, 2025 | 12.41 | +2.99 |
Central Securities | CET | Mar 14, 2025 | 44.92 | +1.15 |
Centrus Energy A | LEU | Mar 14, 2025 | 76.38 | +6.14 |
Centuri Holdings | CTRI | Mar 14, 2025 | 15.74 | +0.58 |
Centurion Acquisition | ALFUU | Mar 14, 2025 | 10.25 | 0.00 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.